Advisors Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-482
Closed -$73.6K 1443
2021
Q1
$73.6K Buy
482
+160
+50% +$24.2K ﹤0.01% 1372
2020
Q4
$41K Sell
322
-103
-24% -$11.9K ﹤0.01% 1443
2020
Q3
$47.5K Hold
425
﹤0.01% 1410
2020
Q2
$34.5K Sell
425
-1
-0.2% -$81 ﹤0.01% 1430
2020
Q1
$29.6K Buy
426
+36
+9% +$2.76K ﹤0.01% 1361
2019
Q4
$30.5K Sell
390
-2,295
-85% -$165K ﹤0.01% 1439
2019
Q3
$171K Buy
+2,685
New +$237K ﹤0.01% 1214

Other funds holding GH

Advisors Asset Management's GH Position: Q2 2021 in Review

Advisors Asset Management sold out of Guardant Health (GH) in Q2 2021, closing a stake of 482 shares — an estimated $73.6K sold.

Advisors Asset Management first reported a position in GH in Q3 2019 and held it in 7 quarters. The position peaked at $171K in Q3 2019. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Advisors Asset Management reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Advisors Asset Management sold 482 Guardant Health shares in Q2 2021, an estimated $73.6K.
  • Advisors Asset Management first reported a position in Guardant Health in Q3 2019 and held it in 7 quarters.
  • Advisors Asset Management's Guardant Health position peaked at $171K in Q3 2019.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Advisors Asset Management's 13F filing for Q2 2021, filed 30 Jul 2021.